These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22300329)

  • 1. Significance of Group III and IV muscle afferents for the endurance exercising human.
    Amann M
    Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):831-5. PubMed ID: 22300329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Influence of Group III/IV Muscle Afferent Feedback on Endurance Exercise Performance.
    Amann M; Wan HY; Thurston TS; Georgescu VP; Weavil JC
    Exerc Sport Sci Rev; 2020 Oct; 48(4):209-216. PubMed ID: 32658041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensemble Input of Group III/IV Muscle Afferents to CNS: A Limiting Factor of Central Motor Drive During Endurance Exercise from Normoxia to Moderate Hypoxia.
    Amann M; Dempsey JA
    Adv Exp Med Biol; 2016; 903():325-42. PubMed ID: 27343106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic responses to exercise: group III/IV muscle afferents and fatigue.
    Amann M; Sidhu SK; Weavil JC; Mangum TS; Venturelli M
    Auton Neurosci; 2015 Mar; 188():19-23. PubMed ID: 25458423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group III/IV muscle afferents limit the intramuscular metabolic perturbation during whole body exercise in humans.
    Blain GM; Mangum TS; Sidhu SK; Weavil JC; Hureau TJ; Jessop JE; Bledsoe AD; Richardson RS; Amann M
    J Physiol; 2016 Sep; 594(18):5303-15. PubMed ID: 27241818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans.
    Amann M; Blain GM; Proctor LT; Sebranek JJ; Pegelow DF; Dempsey JA
    J Physiol; 2011 Nov; 589(Pt 21):5299-309. PubMed ID: 21878520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central alterations of neuromuscular function and feedback from group III-IV muscle afferents following exhaustive high-intensity one-leg dynamic exercise.
    Pageaux B; Angius L; Hopker JG; Lepers R; Marcora SM
    Am J Physiol Regul Integr Comp Physiol; 2015 Jun; 308(12):R1008-20. PubMed ID: 25855308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic stability and physiological adaptation of muscle under conditions of exercise].
    Decherchi P; Dousset E; Grélot L
    Rev Neurol (Paris); 2004 Mar; 160(3):297-305. PubMed ID: 15037842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barosensory cells in the nucleus tractus solitarius receive convergent input from group III muscle afferents and central command.
    Degtyarenko AM; Kaufman MP
    Neuroscience; 2006 Jul; 140(3):1041-50. PubMed ID: 16626870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological attenuation of group III/IV muscle afferents improves endurance performance when oxygen delivery to locomotor muscles is preserved.
    Hureau TJ; Weavil JC; Thurston TS; Wan HY; Gifford JR; Jessop JE; Buys MJ; Richardson RS; Amann M
    J Appl Physiol (1985); 2019 Nov; 127(5):1257-1266. PubMed ID: 31513446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral fatigue limits endurance exercise via a sensory feedback-mediated reduction in spinal motoneuronal output.
    Amann M; Venturelli M; Ives SJ; McDaniel J; Layec G; Rossman MJ; Richardson RS
    J Appl Physiol (1985); 2013 Aug; 115(3):355-64. PubMed ID: 23722705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pre-induced fatigue vs. concurrent pain on exercise tolerance, neuromuscular performance and corticospinal responses of locomotor muscles.
    Aboodarda SJ; Iannetta D; Emami N; Varesco G; Murias JM; Millet GY
    J Physiol; 2020 Jan; 598(2):285-302. PubMed ID: 31826296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of group III and IV muscle afferents to dynamic exercise.
    Adreani CM; Hill JM; Kaufman MP
    J Appl Physiol (1985); 1997 Jun; 82(6):1811-7. PubMed ID: 9173945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III-IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure.
    Poon CS; Song G
    Respir Physiol Neurobiol; 2015 Sep; 216():78-85. PubMed ID: 25911558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point: Afferent feedback from fatigued locomotor muscles is an important determinant of endurance exercise performance.
    Amann M; Secher NH
    J Appl Physiol (1985); 2010 Feb; 108(2):452-4; discussion 457; author reply 470. PubMed ID: 19729588
    [No Abstract]   [Full Text] [Related]  

  • 16. New perspectives concerning feedback influences on cardiorespiratory control during rhythmic exercise and on exercise performance.
    Dempsey JA
    J Physiol; 2012 Sep; 590(17):4129-44. PubMed ID: 22826128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discharge properties of group III and IV muscle afferents.
    Kaufman MP; Hayes SG; Adreani CM; Pickar JG
    Adv Exp Med Biol; 2002; 508():25-32. PubMed ID: 12171119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'sensory tolerance limit': A hypothetical construct determining exercise performance?
    Hureau TJ; Romer LM; Amann M
    Eur J Sport Sci; 2018 Feb; 18(1):13-24. PubMed ID: 27821022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fatigue-related group III/IV afferent firing on intracortical inhibition and facilitation in hand muscles.
    Latella C; van der Groen O; Ruas CV; Taylor JL
    J Appl Physiol (1985); 2020 Jan; 128(1):149-158. PubMed ID: 31725359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans.
    Amann M; Proctor LT; Sebranek JJ; Pegelow DF; Dempsey JA
    J Physiol; 2009 Jan; 587(1):271-83. PubMed ID: 19015193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.